 Multimodality therapy advanced recurrent vulvar squamous cell carcinoma pilot project women advanced recurrent vulvar carcinoma Women Cancer Center University Minnesota Hospital Clinic combination mitomycin cisplatin radiotherapy women posttreatment radical vulvectomy acceptable operative morbidity patients complete clinical response residual disease surgical specimen patient recurrent vulvar carcinoma progression disease therapy death attributable toxicity patients intercurrent disease overall survival rate months multimodality approach treatment advanced vulvar carcinoma therapeutic approach extensive resistant vulvar carcinoma